We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

964 hedge funds and large institutions have $48B invested in Thermo Fisher Scientific in 2015 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 336 increasing their positions, 398 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more call options, than puts

Call options by funds: $260M | Put options by funds: $149M

24% more first-time investments, than exits

New positions opened: 83 | Existing positions closed: 67

12% more funds holding in top 10

Funds holding in top 10: 6775 (+8)

5% more capital invested

Capital invested by funds: $45.5B → $48B (+$2.45B)

0% more funds holding

Funds holding: 960964 (+4)

0.79% less ownership

Funds ownership: 90.96%90.17% (-0.79%)

16% less repeat investments, than reductions

Existing positions increased: 336 | Existing positions reduced: 398

Holders
964
Holders Change
+4
Holders Change %
+0.42%
% of All Funds
25.69%
Holding in Top 10
75
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+11.94%
% of All Funds
2%
New
83
Increased
336
Reduced
398
Closed
67
Calls
$260M
Puts
$149M
Net Calls
+$112M
Net Calls Change
+$59.7M
Name Holding Trade Value Shares
Change
Change in
Stake
RWM
301
RKL Wealth Management
Pennsylvania
$8.97M +$305K +2,365 +4%
ANI
302
American National Insurance
Texas
$8.86M
AP
303
Appleton Partners
Massachusetts
$8.8M +$313K +2,429 +4%
FCI
304
Financial Counselors Inc
Kansas
$8.76M +$353K +2,740 +4%
SRC
305
Shufro Rose & Co
New York
$8.73M -$140K -1,085 -2%
Janus Henderson Group
306
Janus Henderson Group
United Kingdom
$8.67M -$134K -1,041 -2%
BNP Paribas Asset Management
307
BNP Paribas Asset Management
France
$8.53M +$1.87M +14,529 +30%
EWM
308
Endurance Wealth Management
Rhode Island
$8.46M -$60.2K -467 -0.7%
CIBC Asset Management
309
CIBC Asset Management
Ontario, Canada
$8.27M -$18.7K -145 -0.2%
CTA
310
Chesley Taft & Associates
Illinois
$8.25M -$476K -3,695 -6%
DG
311
Davidson & Garrard
Virginia
$8.18M -$54.9K -426 -0.7%
RJA
312
Raymond James & Associates
Florida
$8.1M +$590K +4,580 +8%
Fifth Third Bancorp
313
Fifth Third Bancorp
Ohio
$8.08M -$122K -945 -2%
NG
314
NatWest Group
United Kingdom
$8.07M -$133K -1,034 -2%
PWP
315
Private Wealth Partners
California
$8.05M -$645K -5,000 -8%
HHMI
316
Howard Hughes Medical Institute
Maryland
$8.01M -$444K -3,447 -5%
Jones Financial Companies
317
Jones Financial Companies
Missouri
$7.91M +$253K +1,964 +3%
TRSOTSOK
318
Teachers Retirement System of the State of Kentucky
Kentucky
$7.87M -$297K -2,300 -4%
FWCM
319
First Western Capital Management
California
$7.74M -$378K -2,930 -5%
LPL Financial
320
LPL Financial
California
$7.71M +$76.3K +592 +1%
GXMC
321
Global X Management Company
New York
$7.68M +$301K +2,334 +4%
B
322
BP
United Kingdom
$7.66M -$6.83M -53,000 -48%
GH
323
GAM Holding
Switzerland
$7.63M +$122K +946 +2%
PPCM
324
Pillar Pacific Capital Management
California
$7.53M +$129K +1,003 +2%
KPCM
325
Kings Point Capital Management
New York
$7.43M +$369K +2,860 +5%

TMO Hedge Fund Activity: Q1 2015 in Review

964 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2015, worth a combined $48B — up 5.4% from $45.5B a quarter earlier.

Buyers outnumbered sellers: 83 funds opened new TMO positions and 67 closed out — a net gain of 16 holders — while 336 added to existing stakes and 398 trimmed.

The largest buyer was Capital World Investors, adding an estimated $324M. The largest seller was Glenview Capital Management, cutting an estimated $577M.

  • 964 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2015, up from 960 in Q4 2014.
  • Funds reported $48B of Thermo Fisher Scientific stock for Q1 2015, up 5.4% quarter-over-quarter.
  • 83 funds opened new Thermo Fisher Scientific positions in Q1 2015 and 67 closed out, a net change of +16 holders.
  • The largest Thermo Fisher Scientific buyer in Q1 2015 was Capital World Investors, an estimated $324M added.
  • The largest Thermo Fisher Scientific seller in Q1 2015 was Glenview Capital Management, an estimated $577M sold.

Based on aggregated 13F filings for Q1 2015.